Association of Timing for Starting Dual Antiplatelet Treatment With Cilostazol and Recurrent Stroke: A CSPS.com Trial Post Hoc Analysis.
Kazunori ToyodaKatsuhiro OmaeHaruhiko HoshinoShinichiro UchiyamaKazumi KimuraKaori MiwaKazuo MinematsuKeiji YamaguchiYoshitaka SudaShuta ToruKazuo KitagawaMasafumi IharaMasatoshi KogaTakenori Yamaguchinull nullPublished in: Neurology (2022)
This study provides Class II evidence that for patients with acute noncardioembolic stroke taking either aspirin or clopidogrel, the addition of cilostazol 15-180 days after stroke onset decreases the risk of recurrent ischemic stroke.